Hypereosinophilic Syndrome, Cardiomyopathies, and Sudden Cardiac Death in Superinvasive Opisthorchiasis

Vitaly G Bychkov1, Vladimir M Zolotukhin2, Elena D Khadieva3

  • 1Tyumen State Medical University, Tyumen, Russia.

Insights

Superinvasive opisthorchiasis causes severe cardiovascular pathology, including heart muscle dysfunction. This study details cardiac changes linked to hypereosinophilic syndrome in opisthorchiasis patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathology

Background:

  • Opisthorchiasis is a parasitic infection endemic in certain regions.
  • Superinvasive opisthorchiasis can lead to severe systemic complications.
  • Cardiovascular involvement is a significant concern in opisthorchiasis.

Purpose of the Study:

  • To characterize cardiovascular pathology in patients with superinvasive opisthorchiasis.
  • To identify cardiac changes associated with hypereosinophilic syndrome in opisthorchiasis.
  • To classify and describe the pathogenesis of these cardiac conditions.

Main Methods:

  • Analysis of 578 cases from medical records and autopsy reports.
  • Inclusion of patients from a hyperendemic focus of opisthorchiasis.
  • Classification of pathological processes using ICD-10.

Main Results:

  • Severe changes in hemodynamics and myocardial metabolism were observed.
  • Impaired automatism, excitability, and conduction of the heart muscle were identified.
  • A specific set of cardiac changes associated with hypereosinophilic syndrome and opisthorchiasis was identified.

Conclusions:

  • Superinvasive opisthorchiasis leads to significant cardiovascular pathology.
  • Hypereosinophilic syndrome plays a role in the cardiac manifestations of opisthorchiasis.
  • Understanding the pathogenesis is crucial for managing these complex cases.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
502
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
490
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
440
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
535
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
326
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
365